New study aims to safely harvest stem cells for gene therapy in rare blood disorders
NCT ID NCT07585136
First seen May 13, 2026 · Last updated Jun 05, 2026 · Updated 2 times
Summary
This early-phase study tests whether it is safe and possible to collect blood stem cells from 12 people aged 18 to 25 with bone marrow failure syndromes. Participants receive two drugs (Filgrastim and plerixafor) to move stem cells from bone marrow into the blood, where they are collected. The goal is to gather enough healthy stem cells to advance gene therapy research for these life-threatening conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW FAILURE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105-2794, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.